Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19]

F.I. Mulder,N. van Es,N. Kraaijpoel,M. Di Nisio,M. Carrier, A. Duggal, M. Gaddh,D. Garcia, M.A. Grosso, A.K. Kakkar, M.F. Mercuri,S. Middeldorp,G. Royle, A. Segers,S. Shivakumar,P. Verhamme, T. Wang, J.I. Weitz,G. Zhang, H.R. Büller,G. Raskob

Thrombosis Research（2020）

引用 2|浏览7

暂无评分

摘要

The authors regret that panel E of Fig. 1 was missing, showing the cumulative incidence of the primary outcome in hematologic cancer. The authors would like to apologise for any inconvenience caused.

查看译文

关键词

venous thromboembolism,hokusai vte cancer study”,edoxaban

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要